Umakanthan S, Sahu P, Ranade AV, Bukelo MM, Rao JS, Abrahao-Machado LF, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–8. https://doi.org/10.1136/postgradmedj-2020-138234.
Article
CAS
PubMed
Google Scholar
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. https://doi.org/10.1016/s0140-6736(20)30566-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Faggiano P, Bonelli A, Paris S, Milesi G, Bisegna S, Bernardi N, et al. Acute pulmonary embolism in COVID-19 disease: preliminary report on seven patients. Int J Cardiol. 2020;313:129–31. https://doi.org/10.1016/j.ijcard.2020.04.028.
Article
PubMed
PubMed Central
Google Scholar
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901. https://doi.org/10.1016/j.annonc.2020.03.296.
Article
CAS
PubMed
Google Scholar
Kommoss FKF, Schwab C, Tavernar L, Schreck J, Wagner WL, Merle U, et al. The pathology of severe COVID-19-related lung damage. Dtsch Arztebl Int. 2020;117(29–30):500–6.
PubMed
Google Scholar
Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021;9(3):e002266. https://doi.org/10.1136/jitc-2020-002266.
Article
PubMed
PubMed Central
Google Scholar
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–91. https://doi.org/10.1158/2159-8290.Cd-20-0422.
Article
CAS
PubMed
PubMed Central
Google Scholar
Food and Drug Administration US. COVID-19 vaccinations 2022. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/covid-19-vaccines. Updated 7 Jan 2022; Accessed 1 Jan 2022.
Centers for Disease Control and Prevention US. COVID-19 vaccines for moderately or severely immunocompromised people 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html. Updated 7 Jan 2022; Accessed 9 Jan 2022.
Gandhi L, Rodríguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med. 2018;378(22):2078–92. https://doi.org/10.1056/NEJMoa1801005.
Article
CAS
PubMed
Google Scholar
Rodríguez-Abreu D, Powell SF, Hochmair MJ, Gadgeel S, Esteban E, Felip E, et al. Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189. Ann Oncol. 2021;32(7):881–95. https://doi.org/10.1016/j.annonc.2021.04.008.
Article
CAS
PubMed
Google Scholar
Herbst RS, Baas P, Kim DW, Felip E, Pérez-Gracia JL, Han JY, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540–50. https://doi.org/10.1016/s0140-6736(15)01281-7.
Article
CAS
PubMed
Google Scholar
Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, et al. Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med. 2018;379(21):2040–51. https://doi.org/10.1056/NEJMoa1810865.
Article
CAS
PubMed
Google Scholar
Frelaut M, du Rusquec P, de Moura A, Le Tourneau C, Borcoman E. Pseudoprogression and hyperprogression as new forms of response to immunotherapy. BioDrugs. 2020;34(4):463–76. https://doi.org/10.1007/s40259-020-00425-y.
Article
PubMed
Google Scholar
Cocco G, Delli Pizzi A, Taraschi AL, Boccatonda A, Corvino A, Ucciferri C, et al. Atypical sites of lymphadenopathy after anti-COVID-19 vaccine: ultrasound features. Medicina (Kaunas). 2022;58(2):197. https://doi.org/10.3390/medicina58020197.
Article
PubMed
Google Scholar
Singh B, Kaur P, Kumar V, Maroules M. COVID-19 vaccine induced axillary and pectoral lymphadenopathy on PET scan. Radiol Case Rep. 2021;16(7):1819–21. https://doi.org/10.1016/j.radcr.2021.04.053.
Article
PubMed
PubMed Central
Google Scholar
Doss M, Nakhoda SK, Li Y, Yu JQ. COVID-19 vaccine-related local FDG uptake. Clin Nucl Med. 2021;46(5):439–41. https://doi.org/10.1097/rlu.0000000000003634.
Article
PubMed
Google Scholar
Keshavarz P, Yazdanpanah F, Rafiee F, Mizandari M. Lymphadenopathy following COVID-19 vaccination: imaging findings review. Acad Radiol. 2021;28(8):1058–71. https://doi.org/10.1016/j.acra.2021.04.007.
Article
PubMed
PubMed Central
Google Scholar
Cohen D, Krauthammer SH, Wolf I, Even-Sapir E. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging. 2021;48(6):1854–63. https://doi.org/10.1007/s00259-021-05314-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
McIntosh LJ, Bankier AA, Vijayaraghavan GR, Licho R, Rosen MP. COVID-19 vaccination-related uptake on FDG PET/CT: an emerging dilemma and suggestions for management. Am J Roentgenol. 2021;217(4):975–83. https://doi.org/10.2214/ajr.21.25728.
Article
Google Scholar
McIntosh LJ, Rosen MP, Mittal K, Whalen GF, Bathini VG, Ali T, et al. Coordination and optimization of FDG PET/CT and COVID-19 vaccination; lessons learned in the early stages of mass vaccination. Cancer Treat Rev. 2021;98:102220. https://doi.org/10.1016/j.ctrv.2021.102220.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lehman CD, Lamb LR, D’Alessandro HA. Mitigating the impact of coronavirus disease (COVID-19) vaccinations on patients undergoing breast imaging examinations: a pragmatic approach. Am J Roentgenol. 2021;217(3):584–6. https://doi.org/10.2214/ajr.21.25688.
Article
Google Scholar
Becker AS, Perez-Johnston R, Chikarmane SA, Chen MM, El Homsi M, Feigin KN, et al. Multidisciplinary recommendations regarding post-vaccine adenopathy and radiologic imaging: radiology scientific expert panel. Radiology. 2021;300(2):E323–7. https://doi.org/10.1148/radiol.2021210436.
Article
PubMed
Google Scholar
Lasagna A, Lilleri D, Agustoni F, Percivalle E, Borgetto S, Alessio N, et al. Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up. ESMO Open. 2022;7(1):100359. https://doi.org/10.1016/j.esmoop.2021.100359.
Article
CAS
PubMed
Google Scholar
Khalifehzadeh-Esfahani Z, Fattahi S, Heidari Haratemeh Z, Jafarinia M. The role of immune regulatory molecules in COVID-19. Viral Immunol. 2022;35(5):359–64. https://doi.org/10.1089/vim.2021.0211.
Article
CAS
PubMed
Google Scholar
Al-Mterin MA, Alsalman A, Elkord E. Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients. Front Immunol. 2022;13:870283. https://doi.org/10.3389/fimmu.2022.870283.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rha MS, Jeong HW, Ko JH, Choi SJ, Seo IH, Lee JS, et al. PD-1-expressing SARS-CoV-2-specific CD8(+) T cells are not exhausted, but functional in patients with COVID-19. Immunity. 2021;54(1):44-52.e3. https://doi.org/10.1016/j.immuni.2020.12.002.
Article
CAS
PubMed
Google Scholar
Mortezaee K, Majidpoor J. CD8(+) T cells in SARS-CoV-2 induced disease and cancer-clinical perspectives. Front Immunol. 2022;13:864298. https://doi.org/10.3389/fimmu.2022.864298.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vivarelli S, Falzone L, Leonardi GC, Salmeri M, Libra M. Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review). Int J Oncol. 2021;59(3):75. https://doi.org/10.3892/ijo.2021.5255.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mei Q, Hu G, Yang Y, Liu B, Yin J, Li M, et al. Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study. J Immunother Cancer. 2022;10(3):4157. https://doi.org/10.1136/jitc-2021-004157.
Article
Google Scholar